CA2363965A1 - Protein-induced morphogenesis - Google Patents
Protein-induced morphogenesis Download PDFInfo
- Publication number
- CA2363965A1 CA2363965A1 CA002363965A CA2363965A CA2363965A1 CA 2363965 A1 CA2363965 A1 CA 2363965A1 CA 002363965 A CA002363965 A CA 002363965A CA 2363965 A CA2363965 A CA 2363965A CA 2363965 A1 CA2363965 A1 CA 2363965A1
- Authority
- CA
- Canada
- Prior art keywords
- tissue
- proteins
- residues
- matrix
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/24—Collagen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/28—Materials or treatment for tissue regeneration for liver reconstruction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Physiology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
This invention relates to amino acid sequence data, structural features, homologies and various other data characterizing morphogenic proteins. There is also disclosed methods of producing these proteins form natural and recombinant sources and from synthetic constructs. The invention also relates to morphogenic devices comprising these proteins and a suitably modified tissue-specific matrix. Methods of inducing non-chondrogenic tissue growth in mammals are also disclosed.
The proteins are useful in inducing the developmental cascade of tissue morphogenesis for a variety of tissues in mammals different from bone or cartilage. The proteins of the morphogenic devices comprise a pair of folded polypeptides, the amino acid sequence of each comprises a sequence sharing at least 70% homology with the C-terminal seven-cysteine domain of human OP-1, mouse OP-1, human OP-2 or mouse OP-2, residues 38-139 of Seq. ID Nos. 5, 6, 7 or 8; or an essentially 102 amino acid sequence having cysteine residues at relative positions 1, 30, 34, 66, 67, 99 and 101 therein, wherein at least 70% of amino acid residues within said sequence are selected independently from residues occupying the corresponding positions within residues 38-139 of Seq. ID Nos., 5, 6, 7 or 8, or conservative substitutions of said corresponding residues.
Disclosed are 1) amino acid sequence data, structural features, homologies and various other data characterizing morphog-enic proteins, 2) methods of producing these proteins from natural and recombinant sources and from synthetic constructs, 3) morphogenic devices comprising these morphogenic proteins and a suitably modified tissue-specific matrix, and 4) methods of inducing non-chondrogenic tissue growth in a mammal.
The proteins are useful in inducing the developmental cascade of tissue morphogenesis for a variety of tissues in mammals different from bone or cartilage. The proteins of the morphogenic devices comprise a pair of folded polypeptides, the amino acid sequence of each comprises a sequence sharing at least 70% homology with the C-terminal seven-cysteine domain of human OP-1, mouse OP-1, human OP-2 or mouse OP-2, residues 38-139 of Seq. ID Nos. 5, 6, 7 or 8; or an essentially 102 amino acid sequence having cysteine residues at relative positions 1, 30, 34, 66, 67, 99 and 101 therein, wherein at least 70% of amino acid residues within said sequence are selected independently from residues occupying the corresponding positions within residues 38-139 of Seq. ID Nos., 5, 6, 7 or 8, or conservative substitutions of said corresponding residues.
Disclosed are 1) amino acid sequence data, structural features, homologies and various other data characterizing morphog-enic proteins, 2) methods of producing these proteins from natural and recombinant sources and from synthetic constructs, 3) morphogenic devices comprising these morphogenic proteins and a suitably modified tissue-specific matrix, and 4) methods of inducing non-chondrogenic tissue growth in a mammal.
Claims (5)
1. A composition comprising a) a biocompatible acellular matrix that provides as anchoring substratum for mammalian progenitor cells and is essentially free of substrates that inhibit morphogenesis; and b) a morphogen absorbed on said matrix at a concentration sufficient for inducing the developmental cascade of tissue-specific morphogenesis when said composition is disposed at a non-skeletal tissue locus in vivo, said matrix having components specific for said tissue locus.
2. The composition of claim 1, wherein said matrix is biodegradable and/or porous (being derived from organ-specific tissue or comprising collagen or cell attachment factors selected from glycosaminoglycans and proteoglycans).
3. A composition comprising a morphogen in association with a matrix derived from dehydrated non-skeletal tissue.
4. The composition of claim 1 wherein said matrix is derived from liver tissue or from demineralized dentin.
5. Use of the morphogen of claim 1 in a mammal for:
(a) preventing or inhibiting the formation of scar tissue, and regenerating skin tissue;
(b) the treatment of liver or blood disorders;
(c) increasing protenitor cell populations;
(d) stimulating the proliferation of differentiated cells;
(e) the treatment of osteoporosis;
(f) dentin regeneration;
(g) the healing of gastrointestinal ulcers;
(h) non-skeletal tissue replacement;
(i) neuroprotection or the treatment of degenerative nerve disease; and (j) the treatment of lung tissue damaged by emphyscema.
(a) preventing or inhibiting the formation of scar tissue, and regenerating skin tissue;
(b) the treatment of liver or blood disorders;
(c) increasing protenitor cell populations;
(d) stimulating the proliferation of differentiated cells;
(e) the treatment of osteoporosis;
(f) dentin regeneration;
(g) the healing of gastrointestinal ulcers;
(h) non-skeletal tissue replacement;
(i) neuroprotection or the treatment of degenerative nerve disease; and (j) the treatment of lung tissue damaged by emphyscema.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66727491A | 1991-03-11 | 1991-03-11 | |
US667,274 | 1991-03-11 | ||
US75276491A | 1991-08-30 | 1991-08-30 | |
US752,764 | 1991-08-30 | ||
CA002104678A CA2104678C (en) | 1991-03-11 | 1992-03-11 | Protein-induced morphogenesis |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002104678A Division CA2104678C (en) | 1991-03-11 | 1992-03-11 | Protein-induced morphogenesis |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2363965A1 true CA2363965A1 (en) | 1992-09-17 |
CA2363965C CA2363965C (en) | 2010-05-18 |
Family
ID=27099654
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2363965A Expired - Lifetime CA2363965C (en) | 1991-03-11 | 1992-03-11 | Protein-induced morphogenesis |
CA002104678A Expired - Lifetime CA2104678C (en) | 1991-03-11 | 1992-03-11 | Protein-induced morphogenesis |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002104678A Expired - Lifetime CA2104678C (en) | 1991-03-11 | 1992-03-11 | Protein-induced morphogenesis |
Country Status (2)
Country | Link |
---|---|
US (3) | US6565843B1 (en) |
CA (2) | CA2363965C (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6586388B2 (en) * | 1988-04-08 | 2003-07-01 | Stryker Corporation | Method of using recombinant osteogenic protein to repair bone or cartilage defects |
US6919308B2 (en) * | 1988-04-08 | 2005-07-19 | Stryker Corporation | Osteogenic devices |
US6077823A (en) * | 1991-03-11 | 2000-06-20 | Creative Biomolecules, Inc. | Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury |
US6495513B1 (en) * | 1991-03-11 | 2002-12-17 | Curis, Inc. | Morphogen-enhanced survival and repair of neural cells |
US20080233170A1 (en) * | 1992-02-21 | 2008-09-25 | Stryker Corporation | Osteogenic Proteins |
US6498142B1 (en) | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
EP0980252B1 (en) | 1997-05-05 | 2004-10-06 | Curis, Inc. | Therapies for acute renal failure |
CA2291514C (en) | 1997-05-30 | 2011-07-12 | Creative Biomolecules, Inc. | Methods for evaluating tissue morphogenesis and activity |
BR0214275A (en) | 2001-11-19 | 2004-09-21 | Scil Technology Gmbh | Device having osteoconductive and osteoinductive properties |
ES2260685T3 (en) * | 2002-09-10 | 2006-11-01 | Scil Technology Gmbh | METALLIC IMPLANT COVERED, TO A REDUCED OXYGEN CONCENTRATION, WITH OSTEOINDUCTING PROTEIN. |
WO2005077403A1 (en) * | 2004-02-04 | 2005-08-25 | Stryker Corporation | Therapeutic methods using smads |
EP1802326A2 (en) * | 2004-09-09 | 2007-07-04 | Stryker Corporation | Methods for treating bone tumors using bone morphogenic proteins |
US20080020014A1 (en) * | 2006-07-19 | 2008-01-24 | Paul Consigny | Implantable devices containing nuclear receptor ligands for the treatment of vascular and related disorders |
ES2447516T3 (en) * | 2006-12-21 | 2014-03-12 | Stryker Corporation | Sustained release formulations comprising BMP-7 crystals |
US20150335400A1 (en) * | 2009-06-17 | 2015-11-26 | The Trustees Of Columbia University In The City Of New York | Tooth scaffolds |
US9725689B2 (en) | 2010-10-08 | 2017-08-08 | Terumo Bct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
CN105992816B (en) | 2013-11-16 | 2018-04-17 | 泰尔茂比司特公司 | Cell amplification in bioreactor |
JP6783143B2 (en) | 2014-03-25 | 2020-11-11 | テルモ ビーシーティー、インコーポレーテッド | Passive replenishment of medium |
CN106715676A (en) | 2014-09-26 | 2017-05-24 | 泰尔茂比司特公司 | Scheduled feed |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
EP3464565A4 (en) | 2016-05-25 | 2020-01-01 | Terumo BCT, Inc. | Cell expansion |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
JP7393945B2 (en) | 2017-03-31 | 2023-12-07 | テルモ ビーシーティー、インコーポレーテッド | cell proliferation |
Family Cites Families (63)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2814981C3 (en) * | 1978-04-07 | 1981-08-06 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen | Factor for stimulating the rate of proliferation of liver cells |
US4342828A (en) | 1979-07-20 | 1982-08-03 | Morinaga Milk Industry Co., Ltd. | Method for producing substance capable of stimulating differentiation and proliferation of human granulopoietic stem cells |
US4472840A (en) * | 1981-09-21 | 1984-09-25 | Jefferies Steven R | Method of inducing osseous formation by implanting bone graft material |
EP0105014B1 (en) | 1982-09-24 | 1992-05-20 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Repair of tissue in animals |
IL68218A (en) * | 1983-03-23 | 1985-12-31 | Univ Ramot | Compositions for cartilage repair comprising embryonal chondrocytes |
NZ210699A (en) | 1984-01-04 | 1989-06-28 | Int Genetic Eng | Isolation of an osteogenic protein of the p3 immunologically related family |
US4609551A (en) * | 1984-03-20 | 1986-09-02 | Arnold Caplan | Process of and material for stimulating growth of cartilage and bony tissue at anatomical sites |
US4608199A (en) * | 1984-03-20 | 1986-08-26 | Arnold Caplan | Bone protein purification process |
US4620327A (en) * | 1984-07-05 | 1986-11-04 | Caplan Arnold I | Process of adapting soluble bone protein for use in stimulating osteoinduction |
US4888366A (en) * | 1984-10-24 | 1989-12-19 | Collagen Corporation | Inductive collagen-based bone repair preparations |
US4721096A (en) * | 1986-04-18 | 1988-01-26 | Marrow-Tech Incorporated | Process for replicating bone marrow in vitro and using the same |
US4919939A (en) | 1986-04-29 | 1990-04-24 | Pharmetrix Corporation | Periodontal disease treatment system |
IL83003A (en) | 1986-07-01 | 1995-07-31 | Genetics Inst | Osteoinductive factors |
ZA874681B (en) | 1986-07-01 | 1988-04-27 | Genetics Inst | Novel osteoinductive factors |
US4877864A (en) | 1987-03-26 | 1989-10-31 | Genetics Institute, Inc. | Osteoinductive factors |
US5543394A (en) | 1986-07-01 | 1996-08-06 | Genetics Institute, Inc. | Bone morphogenetic protein 5(BMP-5) compositions |
US5013649A (en) * | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
US5186931A (en) * | 1986-08-06 | 1993-02-16 | Ajinomoto Co., Inc. | Composition and method for supporting bone marrow transplantation |
US5124316A (en) | 1986-11-14 | 1992-06-23 | President And Fellows Of Harvard College | Method for periodontal regeneration |
CA1322714C (en) | 1986-11-14 | 1993-10-05 | Harry N. Antoniades | Wound healing and bone regeneration |
US5035901A (en) * | 1987-10-09 | 1991-07-30 | University Of Kansas | Bone inducing agent from a human osteosarcoma cell line |
EP1225225A3 (en) * | 1988-04-08 | 2003-01-08 | Stryker Corporation | Osteogenic devices |
US5011691A (en) | 1988-08-15 | 1991-04-30 | Stryker Corporation | Osteogenic devices |
WO1989010409A1 (en) | 1988-04-08 | 1989-11-02 | Genetics Institute, Inc. | Bone and cartilage inductive compositions |
US4968590A (en) | 1988-04-08 | 1990-11-06 | Stryker Corporation | Osteogenic proteins and polypeptides |
US4975526A (en) | 1989-02-23 | 1990-12-04 | Creative Biomolecules, Inc. | Bone collagen matrix for zenogenic implants |
US5002488A (en) | 1988-04-12 | 1991-03-26 | Hadaco, Ltd. | Dental implants with resorption preventing means |
US4904259A (en) * | 1988-04-29 | 1990-02-27 | Samuel Itay | Compositions and methods for repair of cartilage and bone |
US4983581A (en) * | 1988-05-20 | 1991-01-08 | Institute Of Molecular Biology, Inc. | Wound healing composition of IGF-I and TGF-β |
EP0368992B1 (en) | 1988-05-31 | 1995-02-15 | Biotechnology Australia Pty. Ltd. | Actions of hormones |
US4935497A (en) | 1988-09-06 | 1990-06-19 | Northwestern University | Dentin chondrogenic inductive agent |
US5106626A (en) | 1988-10-11 | 1992-04-21 | International Genetic Engineering, Inc. | Osteogenic factors |
US4946437A (en) * | 1988-12-02 | 1990-08-07 | Bar-Ilan University | Method for the stimulation of bone marrow cells |
CA2027583A1 (en) | 1989-02-23 | 1990-08-24 | Victor P. Terranova | Periodontal and bone regeneration factor, materials and methods |
ATE162223T1 (en) | 1989-03-28 | 1998-01-15 | Genetics Inst | OSTEOINDUCTIVE COMPOSITIONS |
US5077049A (en) | 1989-07-24 | 1991-12-31 | Vipont Pharmaceutical, Inc. | Biodegradable system for regenerating the periodontium |
WO1991001720A1 (en) * | 1989-08-07 | 1991-02-21 | Herman Wade Schlameus | Composition and method of promoting hard tissue healing |
DE69027961T2 (en) | 1989-09-06 | 1997-01-09 | Takeda Chemical Industries Ltd | Protein, DNA and their use |
US5073373A (en) * | 1989-09-21 | 1991-12-17 | Osteotech, Inc. | Flowable demineralized bone powder composition and its use in bone repair |
US5290558A (en) * | 1989-09-21 | 1994-03-01 | Osteotech, Inc. | Flowable demineralized bone powder composition and its use in bone repair |
ES2118723T3 (en) | 1989-10-17 | 1998-10-01 | Stryker Corp | OSTEOGENIC DEVICES. |
US5236456A (en) | 1989-11-09 | 1993-08-17 | Osteotech, Inc. | Osteogenic composition and implant containing same |
US5108989A (en) * | 1990-04-04 | 1992-04-28 | Genentech, Inc. | Method of predisposing mammals to accelerated tissue repair |
US5197882A (en) | 1990-05-14 | 1993-03-30 | Gary R. Jernberg | Periodontal barrier and method for aiding periodontal tissue regeneration agents |
US5645591A (en) | 1990-05-29 | 1997-07-08 | Stryker Corporation | Synthetic bone matrix |
CA2085134C (en) | 1990-06-15 | 2003-03-18 | Carnegie Institution Of Washington | Gdf-1 |
US5208219A (en) | 1991-02-14 | 1993-05-04 | Celtrix Pharmaceuticals Inc. | Method for inducing bone growth |
US5652337A (en) * | 1991-03-11 | 1997-07-29 | Creative Biomolecules, Inc. | OP-3-induced morphogenesis |
EP0575555B1 (en) | 1991-03-11 | 2001-07-18 | Curis, Inc. | Protein-induced morphogenesis |
US5849686A (en) * | 1991-03-11 | 1998-12-15 | Creative Biomolecules, Inc. | Morphogen-induced liver regeneration |
US6090776A (en) * | 1991-03-11 | 2000-07-18 | Creative Bio Molecules, Inc. | Morphogen treatment of organ implants |
US6194376B1 (en) * | 1991-03-11 | 2001-02-27 | Creative Biomolecules, Inc. | Method for modulating inflammatory response comprising administering morphogen |
DK0592562T3 (en) | 1991-06-25 | 1999-08-30 | Genetics Inst | BMP-9 compositions |
JP3693338B2 (en) | 1991-08-30 | 2005-09-07 | キュリス インコーポレイテッド | Regulation of inflammatory response by induction of tissue morphogenetic factor |
JP3504263B2 (en) | 1991-11-04 | 2004-03-08 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | Recombinant bone morphogenetic protein heterodimers, compositions and uses |
AU681356B2 (en) | 1992-09-16 | 1997-08-28 | Stryker Corporation | Morphogen-induced liver regeneration |
US6498142B1 (en) * | 1996-05-06 | 2002-12-24 | Curis, Inc. | Morphogen treatment for chronic renal failure |
US6034062A (en) * | 1997-03-13 | 2000-03-07 | Genetics Institute, Inc. | Bone morphogenetic protein (BMP)-9 compositions and their uses |
US20030032586A1 (en) | 1997-05-15 | 2003-02-13 | David C. Rueger | Compositions for morphogen-induced osteogenesis |
AU1122099A (en) | 1997-10-27 | 1999-05-17 | Curis, Inc. | Enhancement of morphogen activity |
JP2000119192A (en) | 1998-10-09 | 2000-04-25 | Aventis Pharma Ltd | Mature type protein having antagonistic activity for bone morphogenetic protein |
US20030104977A1 (en) | 2000-03-31 | 2003-06-05 | Ugo Ripamonti | Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
US20040126375A1 (en) * | 2001-01-12 | 2004-07-01 | John Langenfeld | Bone morphogenetic protein-2 in the treatment and diagnosis of cancer |
-
1992
- 1992-03-11 CA CA2363965A patent/CA2363965C/en not_active Expired - Lifetime
- 1992-03-11 CA CA002104678A patent/CA2104678C/en not_active Expired - Lifetime
-
1995
- 1995-03-14 US US08/404,113 patent/US6565843B1/en not_active Expired - Fee Related
-
1999
- 1999-12-15 US US09/464,206 patent/US6531445B1/en not_active Expired - Fee Related
-
2003
- 2003-03-10 US US10/385,064 patent/US7196056B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2104678A1 (en) | 1992-09-12 |
CA2363965C (en) | 2010-05-18 |
US6565843B1 (en) | 2003-05-20 |
CA2104678C (en) | 2002-05-14 |
US7196056B2 (en) | 2007-03-27 |
US6531445B1 (en) | 2003-03-11 |
US20040102373A1 (en) | 2004-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2363965A1 (en) | Protein-induced morphogenesis | |
Helm et al. | Utilization of type I collagen gel, demineralized bone matrix, and bone morphogenetic protein-2 to enhance autologous bone lumbar spinal fusion | |
Chenard et al. | Bone morphogenetic proteins in craniofacial surgery: current techniques, clinical experiences, and the future of personalized stem cell therapy | |
Ripamonti et al. | Tissue morphogenesis and regeneration by bone morphogenetic proteins | |
US5733878A (en) | Morphogen-induced periodontal tissue regeneration | |
JP4895826B2 (en) | Bone morphogenetic protein-2 positive modulator | |
CA1259914A (en) | Methods of bone repair using collagen | |
Malemud | The role of growth factors in cartilage metabolism | |
Vukičević et al. | Discovery and clinical applications of bone morphogenetic proteins | |
Si et al. | Induction of new bone by ceramic bovine bone with recombinant human bone morphogenetic protein 2 and transforming growth factor ß | |
JPH0699322B2 (en) | Wound healing | |
US20220016206A1 (en) | Isoform nell-1 peptide | |
CA2519174A1 (en) | Improved osteoinductive materials | |
Bab et al. | Polypeptide factors regulating osteogenesis and bone marrow repair | |
Dayoub et al. | Human mesenchymal stem cells transduced with recombinant bone morphogenetic protein-9 adenovirus promote osteogenesis in rodents | |
EP2708246B1 (en) | Growth factor anchoring type bone graft material, method for producing growth factor anchoring type bone graft material, kit for producing growth factor anchoring type bone graft material. | |
CA2060208C (en) | Wound healing | |
Becker | Augmentation of regenerative healing in man: A possible alternative to prosthetic implantation | |
Ohba et al. | Tissue engineering of bone and cartilage | |
EP0531425B1 (en) | Combination of IGF-I and TGF-beta for bone regeneration | |
Seyedin | Osteoinduction: A report on the discovery and research of unique protein growth factors mediating bone development | |
AU2003218463A1 (en) | Bone generation by gene therapy | |
JP2000119192A (en) | Mature type protein having antagonistic activity for bone morphogenetic protein | |
EP1591526A2 (en) | Frazzled nucleotide sequences, expression products, compositions and uses | |
Murata et al. | Bone induction in subcutaneous tissue in rats by a newly developed DNA-coated atelocollagen and bone morphogenetic protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |